Company news

Proteomics International Laboratories Ltd. news in 2024

Proteomics International Laboratories Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Novel OxiDx test detects muscle damage in elite athletes

December 30, 2024

Breakthrough results for endometriosis diagnostic blood test

December 29, 2024

Proteomics receives $2.16 million in R&D tax incentive

December 15, 2024

AGM Chairman's Address and Investor Presentation

November 8, 2024

September 2024 Quarterly Activities Report and Appendix 4C

October 21, 2024

Esophageal cancer diagnostic delivers excellent results

September 22, 2024

Update on commercialisation of PromarkerD in the USA

September 10, 2024

Groundbreaking results for type 1 diabetes and kidney health

August 22, 2024

June 2024 Quarterly Activities Report and Appendix 4C

July 29, 2024

Eurobio Scientific to sell PromarkerD DKD test in France

June 23, 2024

Proteomics appoints medical devices sales agency for Europe

June 16, 2024

March 2024 Quarterly Activities Report and Appendix 4C

April 16, 2024

Proteomics signs with Oxford Univ to validate test for Endo

March 24, 2024

PromarkerD US commercialisation & Promarker pipeline update

March 17, 2024

European patent granted for OxiDx technology

February 27, 2024

Study validates biomarkers for oesophageal cancer blood test

January 31, 2024

Study validates biomarkers for endometriosis blood test

January 31, 2024

Proteomics to raise $6.5m through Institutional Placement

January 22, 2024

December 2023 Quarterly Activities Report and Appendix 4C

January 22, 2024

Decks in 2024